987TiP First-in-human dose escalation trial of fourth generation chimeric antigen receptor (CAR) T cell therapy (EU307) in patients with glypican-3 (GPC3) positive hepatocellular carcinoma (HCC)

Autor: Kim, D-Y., Sung, P.S., Kim, B.H., Jang, J.Y., Park, H., Choi, Y., Chang, Y.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S673-S673
Databáze: ScienceDirect